statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	358
CN - Cina	182
SG - Singapore	170
IT - Italia	87
VN - Vietnam	54
BR - Brasile	42
GB - Regno Unito	37
FR - Francia	33
DE - Germania	31
HK - Hong Kong	29
KR - Corea	28
RU - Federazione Russa	14
SE - Svezia	13
FI - Finlandia	12
IN - India	11
CA - Canada	9
BD - Bangladesh	8
BE - Belgio	8
NL - Olanda	8
ID - Indonesia	7
IQ - Iraq	7
JP - Giappone	7
MX - Messico	6
PL - Polonia	5
UA - Ucraina	5
AR - Argentina	4
CL - Cile	4
EC - Ecuador	4
LT - Lituania	4
IE - Irlanda	3
MO - Macao, regione amministrativa speciale della Cina	3
TR - Turchia	3
AE - Emirati Arabi Uniti	2
AT - Austria	2
AU - Australia	2
CH - Svizzera	2
CZ - Repubblica Ceca	2
ES - Italia	2
IL - Israele	2
KG - Kirghizistan	2
PH - Filippine	2
PK - Pakistan	2
PS - Palestinian Territory	2
SA - Arabia Saudita	2
UZ - Uzbekistan	2
VE - Venezuela	2
ZA - Sudafrica	2
BG - Bulgaria	1
BN - Brunei Darussalam	1
CO - Colombia	1
EG - Egitto	1
ET - Etiopia	1
GH - Ghana	1
HU - Ungheria	1
IR - Iran	1
JM - Giamaica	1
KE - Kenya	1
LB - Libano	1
LK - Sri Lanka	1
LV - Lettonia	1
NO - Norvegia	1
PY - Paraguay	1
QA - Qatar	1
TH - Thailandia	1
TN - Tunisia	1
UY - Uruguay	1
Totale	1.245

Nome	#
Development of a novel class of YAP:TEAD interface-3 molecular disruptors to treat colorectal carcinoma	240
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents	189
Identification of Innovative Folate Inhibitors Leveraging the Amino Dihydrotriazine Motif from Cycloguanil for Their Potential as Anti-Trypanosoma brucei Agents	179
Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective	176
Drug discovery of pyrazolo-piperidinone inhibitors targeting YAP:TEAD interaction and development of a fluorescence anisotropy assay for high-throughput screening	156
One Health Approach in Drug Discovery for Leishmaniasis by Targeting Calpain cys-protease.	150
Development of a fluorescent anisotropy displacement assay for the optimization of YAP:TEAD molecular disrupters with anticancer activity	89
IDENTIFICATION OF PYRAZOLO-PIPERIDINONE DERIVATIVES TARGETING YAP-TEAD INTERFACE 3 AS ANTICANCER AGENTS THROUGH INTEGRATED VIRTUAL SCREENING AND MASS SPECTROMETRY PROTEOMICS	74
Totale	1.253

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2022/2023	6	0	0	0	0	0	0	0	0	1	1	4	0
2023/2024	109	17	21	8	8	25	2	3	10	1	0	9	5
2024/2025	312	18	1	9	23	59	44	15	13	35	14	45	36
2025/2026	826	53	58	98	111	100	76	78	33	87	73	37	22
Totale													1.253